Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +56.03%
#3 Glidr Glidr +38.25%
#4 Cysic Cysic +31.67%
#5 Walrus Walrus +25.97%
#6 Humanity Humanity +20.80%
#7 Tutorial Tutorial +17.00%
#8 Enso Enso +15.98%
#9 Velvet Velvet +15.00%
#10 Huma Finance Huma Finance +13.59%
Coin of the day
EXOD EXOD
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
Classifica tra le azioni #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
Prezzo delle azioni
$0.069
Ultima sincronizzazione: 2024-07-22
Capitalizzazione di mercato
$2.06M
Variazione (1 giorno)
-1.43%
Variazione (1 anno)
0.00%
Paese
US
Scambia DermTech, Inc. (DMTK)

Categoria

Healthcare
Utile per DermTech, Inc. (DMTK)
Utile nel Mar 2024 TTM: $-89.63M
Secondo gli ultimi rapporti finanziari di DermTech, Inc., gli utili attuali della società sono $-89.63M. Nel 2022, la società ha registrato un utile di $-116.68M, una diminuzione rispetto a agli utili del 2021, che erano di $-78.34M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di DermTech, Inc. dal 2012 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $-89.63M -11.16%
2023 $-100.89M -13.54%
2022 $-116.68M 48.95%
2021 $-78.34M 114.75%
2020 $-36.48M 85.27%
2019 $-19.69M -2,184.69%
2018 $944.46K -1,574,196.67%
2017 $-60.00 -100.00%
2013 $-5.18M 132.41%
2012 $-2.23M 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
$7.61B -8,589.53%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
$4.76B -5,413.07%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
- -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
$-252.70M 181.94%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
$1.42B -1,689.26%
US